Skip to content

Public FDA record

Z-1001-2011: Varian brand C Series Clinics (Includes Trilogy, and Novalis Tx), Model Numbers: H14, H26, H27, H29, Dist

Recall record Z-1001-2011 for Varian Medical Systems Oncology Systems. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1001-2011
Company in FDA record
Varian Medical Systems Oncology Systems
FDA classification date
Jan 31, 2011
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

A circuit design anomaly whereby a faulty balance potentiometer can lead to an undetected electron beam asymmetry.

Source facts

Action
The firm, Varian Medical Systems, sent an "URGENT MEDICAL DEVICE CORRECTION" letter dated December 1, 2009 via Federal Express to consignees/customers. The letter described the product, problem and actions to be taken by the customers and the firm. The customers were instructed to perform a verification of field symmetry on electron beam energies to determine the threshold and report any field symmetry issues to their local Varian service office for attention. The firm, Varian, is developing new functionality to detect the symptoms of this component failure condition under all conditions of electron beam operations and asserting a beam interlock if it is detected. Note: Varian indicated until the solution can be developed, they will conduct an audit of installed Clinacs to identify those the suspect "blue" electron beam balance potentiometers installed, and will execute a program of prophylactic replacement of these potentiometers. If you require further clarification, please contact your local Varian Customer Support District or Regional Manager at phone: USA and Canada-1-888-VARIANS (888-827-4265); Europe- +41 41 749-8844 or email support-emea@varian.com; North America: support-americas@varian.com; Australia/New Zealand: support-anz@varian.com; South East Asia: seasia.apps.helpdes@varian.com; China/Asia: china.apps.helpdesk@varian.com; Japan: Japan.apps.helpdesk@varian.com; Latin America: soporte.al@varian.com; Internet: Oncology Systems - www.myvarian.com; Varian Medical Systems -www.varian.com
Initiated
2009-12-01
Root cause
Device Design
Terminated
2012-03-14
Distribution
USA and countries including: Algeria, Angola, Argentina, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Belorussia, Bolivia, Brazil, Canada, Chile,, China, Columbia, Costa Rica, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France,French Polynesia, Germany, Guadeloupe, Guatemala, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Ireland, Israel, Italy, Japan, Kazakhstan, Kuwait, Latvia, Lebanan, Luxembourg, Maca, Macedonia, Malaysia, Martinique, Mexico, Moldova, Morocco, Nepal, Netherlands, New Zealand, Norway, Oman, Pakistan,, Philippines, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, South Africa, South Korea,, Spain, Sweden, Switzerland, Syria, Taiwan, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom, and Uruguay..
Recall number
Z-1001-2011
Recall status
Terminated
CDRH record ID
93288
FDA classified
2011-01-31
Recall event number
56354

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗